Velos, Inc., a resource for clinical trials management information systems, today announced that it has signed an agreement with the University of Kansas Medical Center (KU Medical Center).
University of Kansas Medical Center to Deploy Velos eResearch System-Wide
FREMONT, Calif., Dec. 4 /PRNewswire/-Velos, Inc., the recognized leader and trusted resource for clinical trials management information systems, today announced that it has signed an agreement with the University of Kansas Medical Center (KU Medical Center). KU Medical Center will deploy Velos eResearch in a comprehensive, system-wide roll-out that supports the regulatory, administrative, financial and clinical information needs of the institution’s clinical research programs.
KU Medical Center will implement Velos eResearch over a two-year period. The objective of the implementation is to provide medical researchers with state-of-the-art systems to support all major facets of clinical research including IRB, clinical data management, electronic data capture, biospecimen management, patient self-reporting, study administration, budgeting, charge capture, and billing.
“We are very pleased to make this announcement,” said John S. McIlwain, president and CEO of Velos, Inc., “and we are gratified that KU Medical Center has chosen a deployment approach that acknowledges the need for institution-wide control and roll-out, balanced with deep support of individual research and departmental needs.”
“This strategic deployment of an enterprise-wide, clinical research system infrastructure reflects our mission of leadership in the discovery of new knowledge and the improvement of research, education, and patient care,” stated Matthew Mayo, PhD, Center for Biostatistics and Advanced Informatics professor and chair, Department of Biostatistics. “We believe that Velos eResearch will deliver the informatics power to further our efficiency and quality improvement.”
There is no practical limit to the number of protocols KU Medical Center may choose to manage through Velos. Velos eResearch also supports full outcomes management for patients not on clinical trials, allowing investigators a one-stop experience for research data collection and management. By designing to accommodate a range of standards, dictionaries, taxonomies and ontologies in health care, Velos has been able to serve the extremely diverse needs of clinicians and researchers in varying specialties across the research enterprise. At KU, the roll-out will support not only the KU Medical Center but also its affiliates and research partners across the state of Kansas, nationally, and internationally.
“KU Medical Center has worked with Velos at a departmental level for several years, so they are already familiar with our capabilities and commitment to product innovation,” continued McIlwain. “We applaud the foresight of the University of Kansas Medical Center as they take an all-inclusive, strategic approach to leveraging information system infrastructure to support excellence in clinical research.”
About KU Medical Center
The University of Kansas Medical Center prepares students for leadership roles in today's dynamic health care environment in Schools of Medicine, Nursing and Allied Health. KU Medical Center offers more than 2,900 students an innovative curriculum and patient-centered clinical training in partnership with many institutions, including The University of Kansas Hospital. KU Medical Center also is recognized as a leader in biomedical research within the city, state and region.
About Velos
Velos, Inc. is the trusted clinical trial management resource for investigators, sponsors and academic leaders throughout the U.S. Its customers include 21 of the top 25 academic medical centers and research institutions. Among the 100 largest recipients of NIH clinical research funding, Velos customers receive over 50% of NIH extramural grants.
Velos eResearch is deployed for clinical research in all parts of the healthcare enterprise and supports a broad diversity of clinical departments and functional needs. The system fundamentally improves the way data is collected, organized and shared. A pure Internet technology platform, Velos eResearch harnesses advanced powers of the Internet to enable research sites, sponsors, and patients to collaborate in a secure, integrated system platform. System users are freed of redundant data entry and related time delays associated with most clinical research today. With emphasis on workflow, Velos integrates the clinical, administrative and financial information needs of research management.
Founded in 1996, Velos is privately held with headquarters in Fremont, California. For more information, visit http://www.velos.com.
This press release may contain forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those set forth in the forward-looking statements.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.